CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Nova Eye Medical Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Nova Eye Medical Ltd
3-4 Second Avenue
Phone: +61 881045200p:+61 881045200 ADELAIDE, SA  5095  Australia Ticker: EYEEYE

Business Summary
Nova Eye Medical Limited is an Australia-based medical technology company. The Company’s principal activities include the design, development, manufacture, marketing, sale, and distribution of surgical devices for the treatment of glaucoma, a cause of blindness. The Company is also engaged in the commercialization of its ophthalmic laser, 2RT. The Company’s segments include AlphaRET and Glaucoma surgical devices. The Company's AlphaRET segment has 2RT, which is an ophthalmic laser developed for the therapy of patients in the early to intermediate stages of age-related macular degeneration (AMD). 2RT is a patented nano-pause laser device that rejuvenates retinal structures compromised by AMD. The Glaucoma Surgical Devices segment includes the design, manufacture, marketing and sale of the iTrack, iTrack Advance, and the Molteno3 glaucoma surgical device. The Company's manufacturing facilities are located in Fremont, California, and Dunedin, New Zealand.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/20236/30/2023Yes---Yes

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Executive Chairman of the Board VictorPrevin 7/26/2005 7/16/2001
Managing Director, Executive Director ThomasSpurling 1/1/2022 4/1/2011
Joint Company Secretary SimonGray 6/30/2020 6/30/2020
3 additional Officers and Directors records available in full report.

Business Names
Business Name
Ellex Hong Kong Limited
Ellex iScience Inc.
Ellex Medical Lasers Limited
9 additional Business Names available in full report.

General Information
Number of Employees: 130 (As of 6/30/2021)
Outstanding Shares: 214,471,005 (As of 2/14/2024)
Shareholders: 2,532
Stock Exchange: ASX
Fax Number: +61 881045231


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, March 18, 2024